Swiss Alpine plant extracts forthe cosmetics industry
In the heart of the Swiss Alps, the Tauderma research teams, with their long experience in the pharmaceutical industry, are helping to develop ingredients targeted at the cosmetics of tomorrow. Rich in natural active ingredients, with scientifically demonstrated properties, Tauderma Alpine plant extracts are the product of this innovative research. Derived from plants grown in the natural milieu and treated by unique high-tech extraction processes, Tauderma extracts are clinically tested to offer the cosmetics industry safe, efficacious ingredients with high added value.
Tauderma is your privileged partner for the development of cosmetic lines meeting the growing requirements of consumers for safety, efficacy, technology and respect for the environment.
Valais Alps,
Switzerland
This unique region in Europe benefits from exceptional biodiversity, spreading from the shores of Lake Geneva to the highest summits and glaciers of the Alps. It is in this sun-bathed region, protected from human activity, that we grow plants whose extracts contain our active ingredients. Our plants are grown in their natural milieu and with the strictest respect for the environment. If some of them are renowned for their ancestral medicinal virtues, their use in cosmetology is novel and is an exclusive property of Tauderma.
Swiss
high-tech
Our research results in partnership with the most prestigious Swiss research institutions, our solvent-free extraction process guarantees us a natural extract rich in active ingredients with a preserved potential, making it the ideal component for your cosmetics line with high added value. All our extracts are tested and controlled in compliance with the legislation in force and undergo the most rigorous quality controls.
Cutting-edge
science
Tauderma’s founders are renowned doctors and scientists who have spent their career in the health industry at a high level. The expertise and methodologies used at Tauderma directly come from this in-depth experience. The scientific rigor and research on efficacy deployed throughout the research processes, then during the production of the active ingredients, give Tauderma a unique position in the sector of natural extracts aimed at cosmetics.
Valais Alps, Switzerland
This unique region in Europe benefits from exceptional biodiversity, spreading from the shores of Lake Geneva to the highest summits and glaciers of the Alps. It is in this sun-bathed region, protected from human activity, that we grow, in their natural milieu, plants whose extracts are our active ingredients, and with the strictest respect for the environment. If some of them have ancestral virtues, their use in cosmetology is a first and a Tauderma exclusivity.
Swiss high-tech
Our research results in partnership with the most prestigious Swiss research institutions, our solvent-free extraction process guarantees us a natural extract rich in active ingredients with a preserved potential, making it the ideal component for your cosmetics line with high added value. All our extracts are tested and controlled in compliance with the legislation in force and undergo the most rigorous quality controls.
Cutting-edge science
Tauderma’s founders are renowned doctors and scientists who have spent their career in the health industry at a high level. The expertise and methodologies used at Tauderma directly come from this in-depth experience. The scientific rigor and research on efficacy deployed throughout the research processes, then during the production of the active ingredients, give Tauderma a unique position in the sector of natural extracts aimed at cosmetics.
Tauderma’s vision
Subject to burning from high-altitude cold and sun, extreme dryness and torrential rain, wind and snow, Alpine plants have adapted to make light of the most hostile elements.
This wealth, the product of thousands of years of evolution, is at the heart of Tauderma’s research. Our skin is also subject on a daily basis to aggressions from the weather and time. Through its Alpine plant extracts, Tauderma concentrates nature-proven solutions to make them available to efficacious cosmetic lines that respect the environment.
Specialized in inflammatory mechanisms and pharmaceutical development, the Tauderma medical team contributes its scientific rigor to the development of natural extracts rich in active ingredients for cosmetic use. We would like everyone to be able to experiment with the pleasure of taking care of his or her appearance by using highly efficient, clinically tested, safe, pleasant and innovative products.
The high-tech processes that Tauderma has exclusively developed aim at preserving intact the extraordinary virtues of Swiss Alpine plants. We only work on extracts in order to preserve the subtle combinations and balance that nature took so long to forge. Our cultivations are done in the plant’s natural biotope, respecting the seasons and the soil so as not to denature and to preserve the mountain environment that surrounds it. Our exclusive extraction processes were specially developed to guarantee the purity and safety of our plant extracts and their active ingredients.
The Tauderma management team
Eduard Vidovic
Vincent Mutel
Silvia Scherer
Gilles Bos
Eduard Vidovic · CEO · has over 17 years of experience in the pharmaceutical and biotech sector, notably in clinical development, medical affairs, fundraising and corporate restructuring.
Before cofounding Tauderma, Eduard was medical director at Synthelabo Pharma, head of medical affairs at Sanofi Aventis and chief medical officer at Creabilis, a company specialized in dermatology. His career has covered the private as well as the public sector with 10 years of clinical experience. Formerly, chief resident at the University Hospital of Geneva and consultant at the Hôpital de la Tour, he holds the title ECMP/FMH of specialist in pharmaceutical medicine. Eduard obtained his medical degree from the University of Zagreb and his PhD from the University of Geneva.
Vincent Mutel · Chairman & CSO · is cofounder and chairman of the Board of Directors. Vincent worked as research and development director in the Hoffmann-La Roche pharmaceutical company and was cofounder, CEO and a member of the Board of Directors of the Addex Pharmaceutical biotech company based in Geneva, which he brought to the stock exchange in 2007. Since 2012, Vincent has also been cofounder, CEO and a member of the Board of Directors of the Inflamalps SA company, a biotech firm specialized in research and development of products for ophthalmology.
Silvia Scherer · Marketing Manager · Silvia Scherer has spent her entire career in the sale and marketing of pharmaceutical and medical products. She has also taken part in creating companies specialized in medical and cosmetic devices. A graduate of the University of Heidelberg, Silvia started at Glaxo, before entering Novartis as sales manager for Germany, then becoming director for Europe in the ophthalmological division of the Hoya group. After merging her first company with Cornéal and launching the Juvederm brand, Silvia cofounded Anteis in Geneva, a structure specialized in hyaluronic acid applications, which she sold to Merz after obtaining many international prizes. Today, she is the CEO of two companies: Hairstetics, active in the development and manufacturing of synthetic hair implants; and Medaesthetics, specialized in consulting for the pharmaceutical, biomedical and cosmetics industries.
Gilles Bos · Business Development · A successful entrepreneur, Gilles has devoted his career to the development of new technologies in the health sector.
He first worked as an engineer in developing innovative implants, instruments and equipment used in eye surgery.
More recently, Gilles cofounded and ran the Anteis SA company, notably active in hyaluronic acid and anti-aging injectable products. Since 2013, Gilles has devoted himself to the financing and development of SMEs in different sectors.
Tauderma products
Tauderma plant extracts are the fruit of years of research on the properties of Alpine plants, conducted in Switzerland in our laboratories in collaboration with the most prestigious research institutions. The manufacturing of our extracts is done under strict scientific control at every stage, according to internal procedures that follow the very demanding standards and procedures of the healthcare industry. All our products meet the European legal standards in force for cosmetic use.
The continuous research carried out at Tauderma since 2014 has enabled us to examine nearly 120 Alpine plants and to initially choose two of them for their exceptional properties: SRX01 et AMX01. The potential for discovering new extracts that have a high cosmetic efficacy potential in this library of little-known plants is considerable.
SRX01 is a natural plant extract with properties of modulatingthe processes involved in skin ageing.Marketing planned for early 2017.
SRX01 is an Alpine plant extract whose patent was filed and which is produced following Tauderma’s rigorous standards. It has exceptional anti-aging virtues. This extract has demonstrated a capacity for modulating the inflammatory processes linked to the expression of collagenase and elastase. It successfully passed all the test and validation phases (stability, efficacy, clinical studies, toxicological studies) and is currently in its marketing pilot phase. The Alpine plant from which it is derived has not been the focus of any cosmetology application until now and is a Tauderma discovery.
It has the following actions:
More generally, this extract has the properties below:
This extract has specific properties that make itan asset of choice in the fight against acne.
Our teams are available to you for any information on incorporating the SRX 01 and AMX 01 extracts in your cosmetics line.
Tauderma Partners
Tauderma relies on a network of prestigious scientific and industrial partners benefiting from the support of the Swiss Confederation. Tauderma’s Switzerland-based scientific partners are on the cutting edge of expertise in R&D, industrial engineering and life sciences. Their research centers, laboratories and production sites are all located in the Swiss Alps, benefiting from the latest technologies and are close to the natural biotope of the plants that Tauderma uses. Its industrial partner, based in France, has both cosmetic and pharmaceutical expertise.
PhytoArk is a high-tech business incubator dedicated to developing natural ingredients, and in particular Alpine plants. PhytoArk is part of the foundation The Ark, created by the Canton of Valais to promote the development of companies with very high added value, in the sectors of information technology, life sciences, the environment and energy. PhytoArk hosts Tauderma’s corporate headquarters, as well as its main production site.
Tauderma has an exclusivity on screening from PhytoArk’s Alpine plant extract library so that it can isolate and use extracts intended for the cosmetics industry.
HES-SO Valais is part of the network of specialized higher institutes of learning of Switzerland. This pole of excellence manages over 1,000 research projects through its 500 employees and 2,000 students.
Notably specialized in the engineering of industrial and technological systems of the living, HES-SO Valais is in charge of developing the solvent and bacteria-free extraction process created by Tauderma.
A research institute founded in 1988 by the Swiss Confederation, the Canton of Valais and the Dalle Molle Foundation, Mediplant is devoted to the study of medicinal plants and their development.
MediPlant, which steers the extraction platform of the PhytoArk incubator, handles the production of Tauderma’s extracts, including the cultivation of plants, the harvest, extraction and packaging of the final extract. Mediplant is also responsible for quality control, through its own laboratories and those of specialized contracting parties.
Specialized in the subcontracting of pharmaceutical and cosmetic products, P&B Group, based in France, has an industrial complex and the expertise required to offer brands a complete service ranging from R&D to packaging, as well as manufacturing. P&B Group also has, among others, ECOCERT certifications for the production of organic cosmetics, FDA approval for the American market and the ISO 13485 standard for manufacturing medical devices. It is a partner of choice for the development and marketing of cosmetic products incorporating Tauderma extracts.
Contact
Corporate headquarters, R&D and production
Tauderma SA · Route des Eterpys 22 · 1964 Conthey · Switzerland
Office: +41 22 510 57 22 · Fax: +41 22 510 57 11· info@tauderma.com
Marketing and Business Development
8 Avenue des Grandes Communes, 1213 Petit Lancy· Switzerland
Office: +41 22 510 57 22 · Fax: +41 22 510 57 11 · business@tauderma.com